A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.
A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.
复制标题
DOI:
10.1016/j.biopsych.2012.12.007
复制
发表时间:
2013-07-01
影响因子:
10.6
通讯作者:
Perlis, Roy H.
中科院分区:
文献类型:
--
作者:
Perlis, Roy H.
关键词:
Early identification of depressed individuals at high risk for treatment-resistance could be helpful in selecting optimal setting and intensity of care. At present, validated tools to facilitate this risk stratification are rarely used in psychiatric practice. Data were drawn from the first two treatment levels of a multicenter antidepressant effectiveness study in major depressive disorder, the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort. This cohort was divided into training, testing, and validation subsets. Only clinical or sociodemographic variables available by, or readily amenable to, self-report were considered. Multivariate models were developed to discriminate individuals reaching remission with a first or second pharmacologic treatment trial from those not reaching remission despite two trials. A logistic regression model achieved an area under the receiver operating characteristic curve (AUC) exceeding 0.71 in training, testing and validation cohorts, and maintained good calibration across cohorts. Performance of three alternative models using machine learning approaches–a naïve Bayes classifier and a support vector machine, and a random forest model – was less consistent. Similar performance was observed between more and less severe depression, males and females, and primary versus specialty care sites. A web-based calculator was developed which implements this tool and provides graphical estimates of risk. Risk for treatment-resistance among outpatients with major depressive disorder can be estimated using a simple model incorporating baseline sociodemographic and clinical features. Future studies should examine the performance of this model in other clinical populations and its utility in treatment selection or clinical trial design. Sequential Treatment Alternatives to Relieve Depression (STAR*D); NCT00021528; www.star-d.org
登录
查看更多内容
影响因子:
37.8
作者:
Cook, Nancy R.
通讯作者:
Cook, Nancy R.
DOI:
10.1111/j.1532-5415.1968.tb02103.x
发表时间:
1968-01-01
影响因子:
6.3
作者:
LINN, BS;LINN, MW;GUREL, L
通讯作者:
GUREL, L
影响因子:
1.7
作者:
Austin, Peter C.;Lee, Douglas S.;Tu, Jack V.
通讯作者:
Tu, Jack V.
影响因子:
4.8
作者:
Burges, CJC
通讯作者:
Burges, CJC
影响因子:
4.6
作者:
Grove, WM;Lloyd, M
通讯作者:
Lloyd, M